<DOC>
	<DOC>NCT01960634</DOC>
	<brief_summary>This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples. Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice. The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.</brief_summary>
	<brief_title>Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Confirmed diagnosis of melanoma and BRAFV600 Signed Informed Consent Form Unresectable phase III or phase IV melanoma The patients should be starting a treatment for melanoma (either first line or subsequent lines)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>